+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-opioid Pain Patches Market by Technology, Application, Product Type, End User, Distribution Channel, Drug Type - Global Forecast to 2030- Product Image
Non-opioid Pain Patches Market by Technology, Application, Product Type, End User, Distribution Channel, Drug Type - Global Forecast to 2030- Product Image
Sale

Non-opioid Pain Patches Market by Technology, Application, Product Type, End User, Distribution Channel, Drug Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460257
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-opioid Pain Patches Market grew from USD 790.97 million in 2024 to USD 897.06 million in 2025. It is expected to continue growing at a CAGR of 12.92%, reaching USD 1.63 billion by 2030.

Unlocking Insights into the Non-opioid Pain Patch Revolution

The global healthcare ecosystem is witnessing a pivotal shift toward non-opioid pain management solutions, driven by growing awareness of opioid risks and an urgent need for safer alternatives. Transdermal pain patches have emerged as a compelling option, combining targeted drug delivery with sustained release profiles that enhance patient compliance and minimize systemic side effects. By leveraging advanced adhesive technologies and novel active ingredients, these patches are redefining standards of care for both acute and chronic pain conditions.

This executive summary distills key findings from our in-depth study of non-opioid pain patches, outlining critical market drivers, regulatory influences, and competitive dynamics. It surveys transformative trends in materials, application areas, and distribution channels while addressing the imminent impact of U.S. tariffs in 2025. With a detailed segmentation analysis and regional outlook, this overview equips decision-makers with the clarity required to navigate a rapidly evolving landscape and capitalize on emerging opportunities.

Emerging Forces Redefining Pain Management with Patch Therapies

Innovations in adhesive platforms and transdermal matrix designs are propelling pain patch technology into a new era. Microneedle patches, in both dissolvable and solid formats, are enabling enhanced permeability without compromising safety, while reservoir systems with gel or liquid compartments deliver consistent dosing for extended durations. Simultaneously, improvements in acrylic, hydrogel and silicone adhesives are optimizing skin adherence, breathability and patient comfort, supporting broader acceptance among diverse patient cohorts.

Regulatory agencies are increasingly receptive to non-opioid assets, streamlining pathways for novel pain modulators and combination therapies. Drug developers are collaborating with materials engineers to integrate anti-inflammatory compounds, such as capsaicin and nonsteroidal anti-inflammatory drugs, into sophisticated patch platforms. This convergence of pharmacology and materials science is driving a shift from oral and injectable modalities toward minimally invasive, patient-centric transdermal solutions.

At the same time, digital health integration and patient monitoring tools are enhancing adherence tracking and real-world data collection. Coupled with rising demand for sustainable packaging and supply chain resilience, these factors are reshaping competitive differentiation and long-term value creation in the pain patch segment.

Navigating the 2025 U.S. Tariff Wave on Pain Patch Markets

The imposition of new U.S. tariffs in 2025 on key raw materials and finished goods is set to introduce significant cost pressures across the non-opioid pain patch supply chain. Components such as specialized adhesives and high-grade silicone polymers, often imported from established manufacturing hubs, will face elevated duties, challenging manufacturers to absorb or pass along incremental expenses. These dynamics are poised to influence pricing strategies, margin structures and procurement models throughout the value chain.

Stakeholders must anticipate the ripple effects on contract manufacturing organizations and distribution networks. Elevated import costs may compress margins for hospital and retail pharmacy channels, potentially delaying product launches or prompting reformulation efforts to source alternative materials. Procurement teams will need to reevaluate supplier agreements and consider nearshoring to mitigate tariff exposure, while finance leaders must stress-test profit forecasts under various duty scenarios.

Proactive measures, including strategic stockpiling, long-term supplier partnerships and investment in domestic production capabilities, can help to stabilize costs. By leveraging value engineering and process optimization, industry players can preserve competitive pricing without compromising on quality or regulatory compliance. Ultimately, a nuanced understanding of the 2025 tariff landscape will be critical to sustaining growth trajectories and securing market share in an environment of heightened trade uncertainty.

Unveiling Critical Segmentation Patterns Shaping Market Dynamics

A nuanced segmentation framework reveals distinct growth drivers across adhesive technologies, applications and product typologies. When categorized by technology, the market encompasses acrylic adhesive, hydrogel adhesive and silicone adhesive platforms, each offering unique adhesion profiles and biocompatibility attributes. In application terms, the landscape bifurcates into acute pain and chronic pain, with the former encompassing postoperative pain and sports injury pain, and the latter addressing arthritis and neuropathic pain. This duality underscores the need for tailored formulations that balance onset speed with sustained relief.

Product type segmentation further differentiates market offerings into matrix patches, microneedle patches and reservoir patches. Microneedle patches span both dissolvable microneedle and solid microneedle designs, enabling enhanced transdermal transport mechanisms. Reservoir patches are defined by gel reservoir and liquid reservoir configurations that facilitate controlled release kinetics. These structural distinctions influence device complexity, manufacturing costs and patient preference, guiding investment priorities and pipeline strategies.

End user segmentation highlights adoption across clinics, home care environments and hospitals, with hospital settings segmented into private hospitals and public hospitals. Distribution channels comprise hospital pharmacy, online pharmacy and retail pharmacy, the latter subdivided into over-the-counter and prescription channels. Finally, drug type segmentation includes capsaicin, lidocaine and nonsteroidal anti-inflammatory drugs, each with specific efficacy profiles. Understanding how these segments intersect enables stakeholders to align product development, marketing and sales efforts with the evolving needs of each cohort, maximizing market penetration and therapeutic impact.

Regional Dynamics Driving Growth and Adoption Globally

Regional analysis uncovers divergent trajectories driven by distinct healthcare infrastructures, regulatory frameworks and patient behaviors. In the Americas, established reimbursement mechanisms and widespread provider awareness have accelerated adoption of non-opioid patches, particularly in North America where insurers increasingly favor transdermal platforms over oral regimens. Latin American markets are also showing promise as government initiatives expand access to advanced pain therapies despite budgetary constraints.

Europe, the Middle East & Africa present a complex mosaic. Western European nations benefit from cohesive regulatory alignment and high per-capita healthcare spending, fueling robust uptake of innovative patch formulations. In contrast, select markets in the Middle East are adopting subsidized models to broaden access, while parts of Africa remain nascent, constrained by limited distribution infrastructure and price sensitivity. This region demands localized engagement strategies that account for fragmented reimbursement policies and varying clinical guidelines.

Asia-Pacific is characterized by rapid expansion, underpinned by rising healthcare investment in China, India and Southeast Asia. Japan and Australia maintain mature transdermal markets, leveraging strong regulatory oversight and established clinical networks. Elsewhere in the region, home care adoption is gaining momentum as aging populations and chronic disease prevalence drive demand for user-friendly, outpatient pain management solutions.

Competitive Landscape Highlights Key Industry Innovators

The competitive landscape is anchored by global healthcare conglomerates and specialized pharmaceutical innovators. Leading multinationals are investing heavily in next-generation patch platforms, forming alliances with biotechnology firms to integrate novel analgesic compounds. Their extensive manufacturing infrastructure and established distribution networks provide a formidable launchpad for rapid scale-up and global reach. Meanwhile, regional players are carving niches by focusing on cost-effective formulations and local regulatory expertise, enabling swift market entry in emerging economies.

Strategic collaborations between device engineers and clinical researchers are giving rise to differentiated offerings, such as microneedle patches that combine controlled release with minimal invasiveness. Joint ventures and licensing agreements are becoming increasingly common, reflecting a trend toward shared risk and resource pooling. Additionally, contract manufacturing organizations are expanding their capabilities to support flexible production volumes and accelerate product commercialization timelines.

Market incumbents are reinforcing their competitive moats through targeted acquisitions and portfolio rationalization. By integrating complementary product lines and streamlining operations, they aim to deliver end-to-end solutions that resonate with payers and providers. New market entrants must navigate these established ecosystems by identifying underserved segments and leveraging digital engagement strategies to build brand recognition.

Strategic Imperatives to Seize Market Opportunities

To capitalize on the evolving pain patch market, industry leaders should intensify research and development in microneedle and reservoir systems, focusing on formulations that address both rapid onset and sustained analgesia. Diversifying adhesive portfolios to include more breathable hydrogel options can enhance patient comfort and broaden application across sensitive skin types.

Manufacturers must also preempt trade disruptions by investing in domestic production capabilities or forging long-term partnerships with low-cost, compliant suppliers. Value engineering efforts should be applied to streamline manufacturing processes, reducing unit costs without sacrificing quality or regulatory integrity. Simultaneously, expanding digital distribution channels-particularly online pharmacies-will be critical to reaching home care patients seeking convenient access.

Engagement with payers and policymakers is essential to secure favorable reimbursement pathways, especially for chronic pain indications that demand long-term therapy. Developing compelling health economic dossiers that quantify real-world adherence benefits can fortify negotiations. Finally, embedding sustainability principles into packaging and supply chain operations can differentiate brands in an increasingly environmentally conscious market.

Robust Methodological Framework Underpinning Insights

This study integrates primary research, comprising in-depth interviews with industry executives, clinicians and key opinion leaders, alongside extensive secondary research from peer-reviewed journals, regulatory filings and proprietary databases. Data triangulation ensures consistency and validity, cross-referencing quantitative sales figures with qualitative expert insights. The market segmentation framework was constructed to reflect both clinical relevance and industry practice, covering technology, application, product type, end user, distribution channel and drug type.

A rigorous validation process was employed, including a multi-stage review by subject-matter experts to verify assumptions and identify emerging trends. Statistical techniques were applied to assess historical performance patterns, while scenario analysis evaluated potential impacts of regulatory shifts and trade policies. This robust methodological approach underpins the credibility of the findings and supports sound strategic decision-making.

Concluding Perspectives on Future Trajectories

The non-opioid pain patch sector is on the cusp of transformative growth, driven by material innovations, diversified applications and evolving regulatory support. With tariffs on the horizon, stakeholders must adopt agile strategies that encompass supply chain resilience and cost optimization. Regional divergences present both challenges and opportunities, while competitive dynamics underscore the importance of strategic partnerships and targeted acquisitions.

As the market matures, success will hinge on the ability to deliver differentiated products aligned with patient needs, backed by compelling value propositions for payers and providers. This comprehensive analysis illuminates the pathways for future development, offering a clear roadmap to navigate complexities and maximize long-term value.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Acrylic Adhesive
    • Hydrogel Adhesive
    • Silicone Adhesive
  • Application
    • Acute Pain
      • Postoperative Pain
      • Sports Injury Pain
    • Chronic Pain
      • Arthritis
      • Neuropathic Pain
  • Product Type
    • Matrix Patch
    • Microneedle Patch
      • Dissolvable Microneedle
      • Solid Microneedle
    • Reservoir Patch
      • Gel Reservoir
      • Liquid Reservoir
  • End User
    • Clinics
    • Home Care
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
      • Over-The-Counter
      • Prescription
  • Drug Type
    • Capsaicin
    • Lidocaine
    • Nonsteroidal Anti-Inflammatory Drug
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Hisamitsu Pharmaceutical Co., Inc.
  • Endo International plc
  • Johnson & Johnson
  • Viatris Inc.
  • Perrigo Company plc
  • Haw Par Corporation Limited
  • Upsher-Smith Laboratories, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-opioid Pain Patches Market, by Technology
8.1. Introduction
8.2. Acrylic Adhesive
8.3. Hydrogel Adhesive
8.4. Silicone Adhesive
9. Non-opioid Pain Patches Market, by Application
9.1. Introduction
9.2. Acute Pain
9.2.1. Postoperative Pain
9.2.2. Sports Injury Pain
9.3. Chronic Pain
9.3.1. Arthritis
9.3.2. Neuropathic Pain
10. Non-opioid Pain Patches Market, by Product Type
10.1. Introduction
10.2. Matrix Patch
10.3. Microneedle Patch
10.3.1. Dissolvable Microneedle
10.3.2. Solid Microneedle
10.4. Reservoir Patch
10.4.1. Gel Reservoir
10.4.2. Liquid Reservoir
11. Non-opioid Pain Patches Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Non-opioid Pain Patches Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.4.1. Over-The-Counter
12.4.2. Prescription
13. Non-opioid Pain Patches Market, by Drug Type
13.1. Introduction
13.2. Capsaicin
13.3. Lidocaine
13.4. Nonsteroidal Anti-Inflammatory Drug
14. Americas Non-opioid Pain Patches Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Non-opioid Pain Patches Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Non-opioid Pain Patches Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Hisamitsu Pharmaceutical Co., Inc.
17.3.2. Endo International plc
17.3.3. Johnson & Johnson
17.3.4. Viatris Inc.
17.3.5. Perrigo Company plc
17.3.6. Haw Par Corporation Limited
17.3.7. Upsher-Smith Laboratories, Inc.
17.3.8. Novartis AG
17.3.9. Teva Pharmaceutical Industries Ltd.
17.3.10. Sun Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NON-OPIOID PAIN PATCHES MARKET MULTI-CURRENCY
FIGURE 2. NON-OPIOID PAIN PATCHES MARKET MULTI-LANGUAGE
FIGURE 3. NON-OPIOID PAIN PATCHES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACRYLIC ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HYDROGEL ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY SILICONE ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY SPORTS INJURY PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISSOLVABLE MICRONEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY SOLID MICRONEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GEL RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIQUID RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 76. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 77. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 79. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 80. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 88. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 89. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 91. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 92. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 149. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 150. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 152. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 153. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 161. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 162. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 164. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 165. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 169. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 185. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 186. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 188. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 189. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 193. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 194. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 197. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 198. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 200. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 201. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 205. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 242. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 245. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 246. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 248. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 249. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 253. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 266. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 269. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 270. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 272. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 273. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 277. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 278. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 281. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 282. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 284. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 285. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 289. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 314. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 317. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 318. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY MICRONEEDLE PATCH, 2018-2030 (USD MILLION)
TABLE 320. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY RESERVOIR PATCH, 2018-2030 (USD MILLION)
TABLE 321. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 323. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 325. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 326. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2030 (USD MILLION)
TABLE 329. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TA

Companies Mentioned

The companies profiled in this Non-opioid Pain Patches market report include:
  • Hisamitsu Pharmaceutical Co., Inc.
  • Endo International plc
  • Johnson & Johnson
  • Viatris Inc.
  • Perrigo Company plc
  • Haw Par Corporation Limited
  • Upsher-Smith Laboratories, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 897.06 Million
Forecasted Market Value ( USD ) by 2030 $ 1630 Million
Compound Annual Growth Rate12.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Non-Opioid Pain Patch Market Report 2025 - Product Image

Non-Opioid Pain Patch Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Non-Opioid Pain Patch Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Non-Opioid Pain Patch Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.